Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Qiagen, Fluidigm, 10x Genomics, More

Qiagen AdnaTest ProstateCancerPanel AR-V7 and LungCancer Kits

Qiagen this week launched the AdnaTest ProstateCancerPanel AR-V7 and AdnaTest LungCancer kits at the American Association for Cancer Research annual meeting.
AdnaTest ProstateCancerPanel AR-V7 detects the androgen receptor splice variant 7 in circulating tumor cells (CTCs) of prostate tumor origin isolated from blood samples to investigate potential resistance to drugs for advanced prostate cancer. With an exclusive worldwide license from Johns Hopkins University for nucleic acid detection of the AR-V7 biomarker for diagnostic use, Qiagen is now launching the test for research use.

AdnaTest LungCancer provides insights into the molecular mechanisms of lung cancer through highly specific selection of CTCs, including stem cell-like cells implicated in cancer growth and epithelial-mesenchymal transition, an important marker of cancer therapy resistance. A proprietary set of antibodies provides sensitive detection of lung cancer-associated targets through reverse-transcriptase PCR, and the open system enables users to add targets of interest.


Fluidigm Advanta CFTR NGS Library Prep Assay

Fluidigm has launched the Advanta CFTR NGS Library Prep Assay, a next-generation sequencing library prep workflow for sequencing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Developed for use with the company's Juno system, the assay automates target enrichment of CFTR variants from each of the gene's 27 exons and selected intronic regions using microfluidic technology. The assay can produce 48 to 1,500 or more NGS libraries each week from DNA derived from blood, saliva, or buccal swabs. Each integrated microfluidic circuit features open inlets to simplify the addition of new assay over time, the company said.


10x Genomics Chromium Single-Cell CNV Solution

10x Genomics has launched the Chromium Single-Cell CNV Solution, a scalable technology for rapid and parallel profiling of single-cell genomes. The solution is built on the firm's technology for generating cell beads and gel beads, and enables preparation of hundreds to thousands of single cells for CNV profiling within minutes on either the Chromium Controller or the Chromium Single-Cell Controller. It profiles the genomes of individual cells and can be used for applications such as revealing tumor heterogeneity, characterizing somatic mosaicism of neurons, and authenticating cell line identity and clonal purity. The product also further examines the clonal structure of cancer samples, including spatial distribution across tumor slices and longitudinal changes.


For more new products and services, please visit the New Products page on our website.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.